ESCP Colorectal Robotic Surgery (CRS) Novice Workshop
Approximately 15% of patients show no response to neoadjuvant chemoradiotherapy for the treatment of locally advanced rectal cancer before surgery. August’s Paper of the Month looks at a systematic review aiming to identify biomarkers of innate radioresistant rectal cancer.
ESCP would like to invite members that are interested in treatment of cryptoglandular anal fistula for an international Delphi consensus process to select a Core Outcome Measurement Set.